Get startedLog in
    Picture of Vireo Growth logo

    VREO — Vireo Growth Cashflow Statement

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Vireo Growth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-22.9-33.7-42.5-25.5-28
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items2.4213.12718.911.2
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital7.2-10-3.782.835.54
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accrued Expenses
    Change in Payable / Accrued Expenses
    Change in Taxes Payable
    Net Change in Other Assets & Liabilities
    Cash from Operating Activities-10.9-30.5-18.1-0.966-10.2
    Capital Expenditures-8.45-18-5.56-6.05-11.7
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items21.410.8-0.0552.583.56
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Other Investing Cash Flow
    Cash from Investing Activities12.9-7.21-5.62-3.48-8.13
    Financing Cash Flow Items-0.120———
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities15.925.823.75.2694
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash17.9-12-0.0060.81575.6